Opal Capital’s Merck MRK Stock Holding History

Opal Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Buy	20,497 +8,569	+72%	+$1M	0.47%	69
2026 Q1	$1.43M	Buy	11,928 +9,098	+321%	+$1.05M	0.25%	99
2025 Q4	$327K	Buy	+2,830	New	+$266K	0.08%	126

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Opal Capital's MRK Position: Q2 2026 in Review

Opal Capital increased its Merck (MRK) stake by 72% in Q2 2026, buying an estimated $1M and bringing the position to 20,497 shares worth $2.63M. The position accounts for 0.47% of the portfolio, ranked #69.

Opal Capital first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Opal Capital held 20,497 shares of Merck worth $2.63M as of Q2 2026.
Opal Capital bought 8,569 Merck shares in Q2 2026, an estimated $1M.
Merck made up 0.47% of Opal Capital's portfolio in Q2 2026, its #69 holding.
Opal Capital first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Opal Capital's 13F filing for Q2 2026, filed 5 Aug 2026.